Diagnosis, Treatment and Prevention of Viral Infections
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Virology".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 828
Special Issue Editor
Interests: arenaviruses; bioinformatics; bunyaviruses; diagnostic biomarkers; emerging viruses; hemorrhagic fevers; hantaviruses; non-coding RNAs (microRNAs and siRNAs); RNA vaccine platform; vaccine development; viral metagenomics; virus evolution
Special Issue Information
Dear Colleagues,
Viral infections remain a major global health challenge, contributing significantly to morbidity and mortality worldwide. Advances in molecular biology, diagnostics, and therapeutic strategies have transformed the landscape of viral infection management, offering new opportunities for early detection, effective treatments, and preventive measures. However, the emergence of novel viruses, increasing resistance, and global pandemics highlight the continuous need for innovation and multidisciplinary collaboration in this field.
Diagnosis, treatment, and prevention represent the three fundamental pillars of virology. Accurate and rapid diagnostic tools are essential for detecting viral infections, guiding clinical decision-making, and shaping public health strategies. The development of molecular techniques, such as PCR, next-generation sequencing (NGS), and point-of-care diagnostics, has improved the sensitivity and specificity of viral detection. At the same time, novel biomarkers and immunological approaches are being explored to enhance diagnostic accuracy and facilitate early intervention.
In parallel, significant progress has been made in the treatment of viral infections, particularly with the development of antiviral agents, immunotherapies, and RNA-based therapeutics. Nevertheless, challenges such as drug resistance, viral persistence, and limited therapeutic options for certain viruses remain areas of active research.
Preventive strategies, including vaccination programs and antiviral prophylaxis, have proven highly effective in controlling the spread of infectious diseases. The ongoing development of mRNA vaccines and other novel vaccine platforms demonstrates the potential to combat both existing and emerging viral threats.
As the Guest Editor of this Special Issue, I would like to invite original research articles, reviews, and short communications focusing on the diagnosis, treatment, and prevention of viral infections. Contributions exploring innovative technologies, translational approaches, and real-world applications are particularly welcome.
Dr. Alexandro Guterres
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- viral infections
- molecular diagnostics
- antiviral therapies
- RNA-based vaccines
- point-of-care testing
- emerging viruses
- drug resistance
- immunotherapy
- viral biomarkers
- prevention strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
